Hey there, lab enthusiasts! Boost your research efficiency with AI-assisted literature reading at labcat.com.cn. Dive into the latest scoop: Tumour immunotherapy is revolutionizing cancer treatment, and a new study in Expert Reviews in Molecular Medicine explores the groundbreaking role of iPSCs. These versatile cells are not only key in both active and adoptive immunotherapy but also pave the way for off-the-shelf allogenic products, offering a game-changer in battling the world's second highest cause of death. Tune in to揭秘iPSCs' impact on the future of cancer care.